文献速递类风湿关节炎

护士主导项目对类风湿关节炎合并症筛查与管理的3年纵向研究

Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients.
PubMed 文献 · RMD Open · 2019-06-14

本研究为Comorbidities and Education in Rheumatoid Arthritis 6个月随机对照试验的3年开放扩展研究,纳入769例病情稳定、明确的类风湿关节炎患者,由护士进行合并症咨询。合并症筛查与管理评分从基线36.6±19.9改善至3年时24.3±17.8(p<0.0001),相对改善33%。心血管风险筛查、疫苗接种状态和骨密度检测改善最明显。

要点

  • 护士主导的合并症咨询可使类风湿关节炎患者合并症筛查评分在3年内相对改善33%。
  • 心血管风险筛查、疫苗接种状态和骨密度检测是改善最明显的合并症领域。
  • 尽管有改善,3年时合并症筛查评分仍提示筛查不理想,需持续加强。

核心结论

  • 护士主导的合并症筛查项目在3年内显著改善了类风湿关节炎患者的合并症筛查与管理。

研究设计与样本

  • 开放长期(3年)扩展研究,纳入769例病情稳定、明确的类风湿关节炎患者,由护士进行合并症咨询。

主要发现

  • 合并症筛查评分从基线36.6±19.9改善至3年时24.3±17.8(p<0.0001),相对改善33%。
  • 心血管风险筛查、疫苗接种状态和骨密度检测改善最明显。

关键数值与推荐

  • 合并症筛查与管理评分范围0-100,评分越低表示筛查与管理越好。

临床怎么用

  • 护士主导的干预可用于改善类风湿关节炎患者的合并症筛查与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/PURPOSE: Cardiovascular (CV) risk, cancer, infections and osteoporosis should be screened for in rheumatoid arthritis (RA). The objective was to assess 3-year effects of a nurse visit for comorbidity counselling. METHODS: This was an open long-term (3 years) extension of the Comorbidities and Education in Rheumatoid Arthritis 6-month randomised controlled trial in which patients with definite, stable RA were visiting a nurse for comorbidity counselling. Comorbidity status was assessed and nurses provided advice on screening and management, at baseline and 3 years later. A score was developed to quantify comorbidity screening and management: 0-100, where lower scores indicate better screening and management. The score was compared between baseline and 3-year assessment using a Wilcoxon test for paired data. RESULTS: Of the 970 recruited patients, 776 (80%) were followed-up at 2-4 years and 769 (79%) had available data for comorbidities at both time points: mean (±SD) age 58 (±11) years and mean disease duration 14 (±10) years; 614 (80%) were women, the mean Disease Activity Score 28 was 3.0±1.3, and 538 (70%) were receiving a biologic. At baseline, the mean comorbidity screening score was 36.6 (±19.9) and it improved at 3 years to 24.3 (±17.8) (p<0.0001), thus with a relative improvement of 33% (improvement of 12 points). CV risk screening, vaccination status and bone densitometry performance improved the most. CONCLUSIONS: Comorbidity screening was suboptimal but improved notably over 3 years, after a nurse-led programme aiming at checking systematically for comorbidity screening and giving patient advice. This long-term efficacy pleads in favour of nurse-led interventions to better address comorbidities in RA. TRIAL REGISTRATION NUMBER: NCT01315652.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Gossec L, Soubrier M, Foissac F, et al. Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients. RMD Open. 2019. PMID: 31275607. doi:10.1136/rmdopen-2019-000914

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。